Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 3
- Countries
- 0
Exclusivity
Patents and exclusivities
3| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8889722 | MULPLETAlusutrombopag | substance, product | Jul 2028 |
| 8530668 | MULPLETAlusutrombopag | substance, product | Jan 2030 |
| 9427402 | MULPLETAlusutrombopag | product | Sept 2031 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Mulpleta | Lusutrombopag | tablet, film coated, oral | 84230-551NDA |
Compare
Other companies listing lusutrombopag
- Shionogi Pharma Co., Ltd.4 sites · 17 NDC
Enquiry
Common questions
- Is VANCOCIN ITALIA SRL FDA approved?
- VANCOCIN ITALIA SRL holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does VANCOCIN ITALIA SRL make?
- 1 product is listed under VANCOCIN ITALIA SRL in the openFDA NDC Directory, most often as tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.